Biological and mechanical performance of calcium phosphate cements modified with phytic acid

被引:1
|
作者
Steinacker, Valentin C. [1 ]
Weichhold, Jan [2 ]
Renner, Tobias [1 ]
Gubik, Sebastian [1 ]
Vollmer, Andreas [1 ]
Breitenbuecher, Niko [1 ]
Fuchs, Andreas [1 ]
Straub, Anton [1 ]
Hartmann, Stefan [1 ]
Kuebler, Alexander C. [1 ]
Gbureck, Uwe [2 ]
机构
[1] Univ Hosp Wurzburg, Dept Oral & Maxillofacial Plast Surg, Pleicherwall 2, D-97070 Wurzburg, Germany
[2] Univ Hosp Wurzburg, Dept Funct Mat Med & Dent, Pleicherwall 2, D-97070 Wurzburg, Germany
关键词
BETA-TRICALCIUM PHOSPHATE; IN-VITRO RESORPTION; BRUSHITE CEMENT; BONE CEMENTS; PYROPHOSPHATE; DEGRADATION; SUBSTITUTES; GRAFTS;
D O I
10.1007/s10856-024-06805-y
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Calcium phosphate cements, primarily brushite cements, require the addition of setting retarders to ensure adequate processing time and processability. So far, citric acid has been the primary setting retarder used in this context. Due to the poor biocompatibility, it is crucial to explore alternative options for better processing. In recent years, the setting retarder phytic acid (IP6) has been increasingly investigated. This study investigates the biological behaviour of calcium phosphate cements with varying concentrations of IP6, in addition to their physical properties. Therefore cytocompatibility in vitro testing was performed using osteoblastic (MG-63) and osteoclastic (RAW 264.7 differentiated with RANKL) cells. We could demonstrate that the physical properties like the compressive strength of specimens formed with IP6 (brushite_IP6_5 = 11.2 MPa) were improved compared to the reference (brushite = 9.8 MPa). In osteoblast and osteoclast assays, IP6 exhibited significantly better cytocompatibility in terms of cell activity and cell number for brushite cements up to 11 times compared to the brushite reference. In contrast, the calcium-deficient hydroxyapatite (CDHA) cements produced similar results for IP6 (CDHA_IP6_0.25 = 27.0 MPa) when compared to their reference (CDHA = 21.2 MPa). Interestingly, lower doses of IP6 were found to be more effective than higher doses with up to 3 times higher. Additionally, IP6 significantly increased degradation in both passive and active resorption. For these reasons, IP6 is emerging as a strong new competitor to established setting retarders such as citric acid. These cements have potential applications in bone augmentation, the stabilisation of non-load bearing fractures (craniofacial), or the cementation of metal implants.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Biological and mechanical performance and degradation characteristics of calcium phosphate cements in large animals and humans
    Schroeter, Lena
    Kaiser, Friederike
    Stein, Svenja
    Gbureck, Uwe
    Ignatius, Anita
    ACTA BIOMATERIALIA, 2020, 117 : 1 - 20
  • [2] Phytic acid as alternative setting retarder enhanced biological performance of dicalcium phosphate cement in vitro
    Meininger, Susanne
    Blum, Carina
    Schamel, Martha
    Barralet, Jake E.
    Ignatius, Anita
    Gbureck, Uwe
    SCIENTIFIC REPORTS, 2017, 7
  • [3] Controlling degradation in calcium phosphate cements
    Tan, Y. N.
    Patel, S.
    Gbureck, U.
    Grover, L. M.
    ADVANCES IN APPLIED CERAMICS, 2011, 110 (08) : 457 - 463
  • [4] Characterization of calcium phosphate cements modified by addition of amorphous calcium phosphate
    Van den Vreken, Natasja M. F.
    Pieters, Ilse Y.
    Declercq, Heidi A.
    Cornelissen, Maria J.
    Verbeeck, Ronald M. H.
    ACTA BIOMATERIALIA, 2010, 6 (02) : 617 - 625
  • [5] Sudoku of porous, injectable calcium phosphate cements - Path to osteoinductivity
    Vezenkova, Agneta
    Locs, Janis
    BIOACTIVE MATERIALS, 2022, 17 : 109 - 124
  • [6] Influence of polymeric additives on the cohesion and mechanical properties of calcium phosphate cements
    An, Jie
    Wolke, Joop G. C.
    Jansen, John A.
    Leeuwenburgh, Sander C. G.
    JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2016, 27 (03) : 1 - 9
  • [7] Preparation of Calcium Phosphate Cement and Polymethyl Methacrylate for Biological Composite Bone Cements
    Yang, Jun
    Zhang, Kairui
    Zhang, Sheng
    Fan, Jiping
    Guo, Xinhui
    Dong, Weiqiang
    Wang, Shengnan
    Chen, Yirong
    Yu, Bin
    MEDICAL SCIENCE MONITOR, 2015, 21 : 1162 - 1172
  • [8] Compositional Variations in Calcium Phosphate Cement and Poly(Lactic-Co-Glycolic-Acid) Porogens Do Not Affect the Orthotopic Performance of Calcium Phosphate Cement/Poly(Lactic-Co-Glycolic-Acid) Cements
    Grosfeld, Eline-Claire
    van Dijk, Natasja W. M.
    Ulrich, Dietmar J. O.
    Mikos, Antonios G.
    Jansen, John A.
    van den Beucken, Jeroen J. J. P.
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2025, 113 (01)
  • [9] Deterioration of the mechanical properties of calcium phosphate cements with Poly (γ-glutamic acid) and its strontium salt after in vitro degradation
    Liang, Ting
    Gao, Chun-Xia
    Yang, Lei
    Saijilafu
    Yang, Hui-Lin
    Luo, Zong-Ping
    JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS, 2017, 75 : 190 - 196
  • [10] The biological performance of injectable calcium phosphate/PLGA cement in osteoporotic rats
    van de Watering, Floor C. J.
    Laverman, Peter
    Cuijpers, Vincent M.
    Gotthardt, Martin
    Bronkhorst, Ewald M.
    Boerman, Otto C.
    Jansen, John A.
    van den Beucken, Jeroen J. J. P.
    BIOMEDICAL MATERIALS, 2013, 8 (03)